Experts Urge Global View, Focus on Reimbursement for Microarray Firms Developing MDx | GenomeWeb
SAN DIEGO, Calif. (GenomeWeb News) – Industry experts at the Discovery 2 Diagnostics Conference held here this week urged microarray firms developing molecular diagnostic products to take a more global view and focus on reimbursement to increase the likelihood of their products succeeding in the marketplace.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.